| Title |
Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, October 2018
|
| DOI | 10.1007/s00262-018-2267-0 |
| Pubmed ID | |
| Authors |
Laura A. Vitale, Lawrence J. Thomas, Li-Zhen He, Thomas O’Neill, Jenifer Widger, Andrea Crocker, Karuna Sundarapandiyan, James R. Storey, Eric M. Forsberg, Jeffrey Weidlick, April R. Baronas, Lauren E. Gergel, James M. Boyer, Crystal Sisson, Joel Goldstein, Henry C. Marsh, Tibor Keler |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 75 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 28 | 37% |
| Other | 7 | 9% |
| Student > Ph. D. Student | 6 | 8% |
| Student > Doctoral Student | 3 | 4% |
| Student > Bachelor | 3 | 4% |
| Other | 6 | 8% |
| Unknown | 22 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 27 | 36% |
| Biochemistry, Genetics and Molecular Biology | 9 | 12% |
| Agricultural and Biological Sciences | 6 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
| Business, Management and Accounting | 2 | 3% |
| Other | 4 | 5% |
| Unknown | 23 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2022.
All research outputs
#7,229,289
of 23,577,654 outputs
Outputs from Cancer Immunology, Immunotherapy
#979
of 2,948 outputs
Outputs of similar age
#129,055
of 352,244 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#8
of 27 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 2,948 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,244 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.